Titlebook: Renal Failure and Replacement Therapies; Sara Blakeley Book 2008 Springer-Verlag London 2008 Cbcc.Competancy.Critical.Renal.care.critical

Malicious

書目名稱Renal Failure and Replacement Therapies影響因子(影響力)




書目名稱Renal Failure and Replacement Therapies影響因子(影響力)學(xué)科排名




書目名稱Renal Failure and Replacement Therapies網(wǎng)絡(luò)公開度




書目名稱Renal Failure and Replacement Therapies網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Renal Failure and Replacement Therapies被引頻次




書目名稱Renal Failure and Replacement Therapies被引頻次學(xué)科排名




書目名稱Renal Failure and Replacement Therapies年度引用




書目名稱Renal Failure and Replacement Therapies年度引用學(xué)科排名




書目名稱Renal Failure and Replacement Therapies讀者反饋




書目名稱Renal Failure and Replacement Therapies讀者反饋學(xué)科排名

使聲音降低

1864-9998 critically ill patients. This text provides the information necessary to provide care for the nephrology patient in the ICU.978-1-84628-936-1978-1-84628-937-8Series ISSN 1864-9998 Series E-ISSN 1865-3383

notification

相同

hankering

不要不誠(chéng)實(shí)

End-Stage Renal Disease,ber is set to double within the next decade. Patients with end-stage renal disease (ESRD) carry a significantly higher cardiovascular morbidity and mortality compared with the general population. This is because of the “uremic” cardiovascular factors (.). The result is that there will be a growing n

GLIB

Clinical Metabolic Acidosis and Alkalosis, although not all that new (.), way of understanding the mechanism behind acid-base disorders has gained popularity. This chapter starts with just a brief discussion of this approach, because there are several excellent overviews in the literature (.)–(.).

tic-douloureux

End-Stage Renal Disease,rtality compared with the general population. This is because of the “uremic” cardiovascular factors (.). The result is that there will be a growing number of ESRD patients being managed within the intensive care unit (ICU) setting.

Morbid

prostatitis